Antipsychotic drug clozapine found to have significant gastrointestinal side effects

February 24, 2016, University of Otago

New research from the University of Otago, Wellington, and Capital and Coast Health District Health Board (CCDHB) shows that the antipsychotic drug clozapine dramatically slows bowel function. Rarely, this can lead to serious or life-threatening consequences.

About 10,000 New Zealanders have been prescribed since it was first available in New Zealand in 1988. This is the first study of its kind to measure the degree to which the drug slows the gut.

Professor Pete Ellis, Head of Psychological Medicine at the University of Otago, Wellington, says clozapine is a valuable antipsychotic drug that can be effective when other treatments have failed.

"For many people clozapine can be life-changing. Overall, these people live better and longer with clozapine than with other treatments, but it does have considerable side effects, which we need to manage," he says.

"Although clozapine is well known to cause constipation, the rare, but potentially severe consequences of this are not widely recognised. These study results mean we can now start exploring its mechanism of action, with the hope of finding effective treatments to reduce or prevent this impaired gut motility, and help make treatment with clozapine much safer."

The researchers tracked the movement of small markers, which could be seen on X-ray, through the gut of people taking clozapine and other to measure the speed at which food was moving.

"Our study shows that that clozapine slows quite considerably, causing constipation. This ranges from moderate to severe. If it results in complete bowel obstruction, this can have potentially fatal consequences," says study lead author Dr Susanna Every-Palmer, from CCDHB.

"In the past 20 years, this impaired gut motility has contributed to at least four deaths and 11 other serious or life-threatening events (like bowel obstruction) in people using clozapine in New Zealand, so it is important to increase our understanding of how this occurs," she says.

"We found that in patients using clozapine, the markers took four times longer moving through the compared to those on other antipsychotics, or in people on no medication," says Dr Every-Palmer.

"Four out of every five people taking clozapine were affected in this way, irrespective of their gender, age, ethnicity or length of clozapine treatment. Therefore we are recommending that everyone starting on clozapine should be prescribed laxatives, to try to reduce this problem."

Explore further: Clozapine benefits those with tx-resistant schizophrenia

More information: Susanna Every-Palmer et al. Clozapine-treated Patients Have Marked Gastrointestinal Hypomotility, the Probable Basis of Life-threatening Gastrointestinal Complications: A Cross Sectional Study, EBioMedicine (2016). DOI: 10.1016/j.ebiom.2016.02.020

Related Stories

Clozapine benefits those with tx-resistant schizophrenia

December 1, 2015
(HealthDay)—Clozapine reduces symptoms in patients with schizophrenia who don't benefit from other antipsychotic medications, according to research published online Nov. 6 in The American Journal of Psychiatry.

Better options for people with treatment-resistant schizophrenia

November 6, 2015
In real-world settings, patients with schizophrenia whose symptoms do not respond to standard antipsychotic medications have better outcomes if they are switched to clozapine instead of another standard antipsychotic. They ...

Promising new treatments for multiple sclerosis

August 15, 2014
(Medical Xpress)—New treatments for multiple sclerosis (MS) using common anti-psychotic agents have been discovered by Victoria University of Wellington researchers.

Study suggests antipsychotic drugs during pregnancy linked to increased risk of gestational diabetes

July 2, 2012
A study that examined maternal use of antipsychotic drugs during pregnancy suggests that these medications may be linked to an increased risk of gestational diabetes, according to a report in the July issue of Archives of ...

Recommended for you

Depression during pregnancy rises in a generation

July 18, 2018
Anxiety and depressive symptoms during pregnancy have risen by 51 per cent within a generation according to findings from a major study by the University of Bristol published last week [Friday 13 July].

Forty percent of people have a fictional first memory, says study

July 17, 2018
Researchers have conducted one of the largest surveys of people's first memories, finding that nearly 40 per cent of people had a first memory which is fictional.

Celebrating positives improves classroom behavior and mental health

July 17, 2018
Training teachers to focus their attention on positive conduct and to avoid jumping to correct minor disruption improves child behaviour, concentration and mental health.

Algorithm identifies patients best suited for antidepressants

July 17, 2018
McLean Hospital researchers have completed a study that sought to determine which individuals with depression are best suited for antidepressant medications. Their findings, published in Psychological Medicine on July 2, ...

Researchers explore how information enters our brains

July 17, 2018
Think you're totally in control of your thoughts? Maybe not as much as you think, according to a new San Francisco State University study that examines how thoughts that lead to actions enter our consciousness.

Early puberty in white adolescent boys increases substance use risk

July 16, 2018
White adolescent boys experiencing early puberty are at higher risk for substance use than later developing boys, a new Purdue University study finds.

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

oliverlu70
not rated yet Feb 24, 2016
So what are you supposed to do about it, eat more fiber, take a laxative, take probiotics, etc.?

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.